Company Overview
LEXICON PHARMACEUTICALS, INC.
LXRXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
50M
2025 FY
Net Income
-50M
2025 FY
Shares Outstanding
363M
2025 FY
EPS
-0.14USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1062822
Exchange
Nasdaq
Location
US